11 – 20 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
What Makes a Price (un)Fair? Excessive Pharmaceutical Pricing in European Competition Law
2022)(
- Thesis › Doctoral thesis (compilation)
- 2021
-
Mark
Excessive Pharmaceutical Pricing as an Abuse of Dominant Position-The Case of CD Pharma (Denmark)
(
- Contribution to journal › Article
-
Mark
Did the Danish Supreme Court Give the Fashion Industry the Kantian Boot?
(
- Contribution to journal › Article
-
Mark
No-one is safe until everyone is safe – patent waiver, compulsory licensing and COVID-19
(
- Contribution to journal › Article
-
Mark
Let´s dance! excessive royalties and the economic value of music
(
- Contribution to journal › Article
-
Mark
Excessive pricing during the COVID-19 crisis in the EU - An empirical inquiry
(
- Contribution to journal › Article
- 2020
-
Mark
SWEDEN’s Response to COVID-19: A tale of trust, recommendations, and odorous nudges: Available at: https://blog.petrieflom.law.harvard.edu/2020/05/12/sweden-global-responses-covid19/
2020)(
- Other contribution › Miscellaneous
-
Mark
Konkurrensrättsliga aspekter av Corona-krisen
2020) In Dagens juridik(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
De minimis exception when using applied art in marketing materials
(
- Contribution to journal › Article
- 2019
-
Mark
Excessive Pharmaceutical Prices as an Anticompetitive Practice in TRIPS and European Competition Law
(
- Chapter in Book/Report/Conference proceeding › Book chapter